Zydus Pharmaceuticals UK Ltd

SMEUK · BristolCompany No. 14646636

Zydus Pharmaceuticals UK Ltd is a UK limited company, based in Bristol, incorporated in 2023. Has won 13 UK public-sector contracts worth £1.0bn across 3 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£1.0bn

new

Public buyers

stable this month

Top buyer share

96%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 96% of revenue.

NHS England

£972.1m

96%

NHS England North East and Yorkshire Health and Justice

£44.2m

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

Contracts won · 13 total · 7 active · 0 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS National Branded Interim - 1 June 2026	NHS England	Shared contract	£529.1m lot total · 51 suppliers	10 Apr 2026	pending
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£403.7m lot total · 104 suppliers	13 Jan 2026	pending
NHS National Framework for Transition products (Nilotinib and Ticagrelor)	NHS England North East and Yorkshire Health and Justice	Shared contract	£22.1m lot total · 8 suppliers	12 Jun 2025	pending
NHS National Framework for Transition products (Nilotinib and Ticagrelor)	NHS England North East and Yorkshire Health and Justice	Shared contract	£22.1m lot total · 8 suppliers	12 Jun 2025	pending
NHS National Framework for Generics Housekeeping	NHS England	Shared contract	£21.6m lot total · 27 suppliers	10 Nov 2025	pending
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£17.7m lot total · 16 suppliers	13 Jan 2026	pending
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	— lot total · 104 suppliers	—	active
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	— lot total · 16 suppliers	—	active
NHS National Framework for Transition products (Nilotinib and Ticagrelor)	NHS England	Shared contract	— lot total · 7 suppliers	—	active
NHS National Branded Interim - 1 June 2026	NHS England	Shared contract	— lot total · 48 suppliers	—	active
NP49425 Generic and Biosimilar Transition Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 20 suppliers	—	active
NP49425 Generic and Biosimilar Transition Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 7 suppliers	—	active
Gastrointestinal, Endocrine, Nutrition & Blood Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 5 suppliers	—	active

Zydus Pharmaceuticals UK Ltd

Buyer concentration

Contracts won · 13 total · 7 active · 0 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Zydus Pharmaceuticals UK Ltd

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive